undefined undefined undefined

A time of evolution in HFrEF: a new pillar blueprint

Event: ESC Congress 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Access

Like

Fine-tuning patient care: a case-based exploration of finerenone in heart and kidney disease

Event: ESC Congress 2025

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Access

Like

Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Event: Heart Failure 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Access

Like

Treatment of iron deficiency in heart failure: new evidence and practical guidance

Event: Heart Failure 2025

Topic: Anaemia/Iron Deficiency

Session type: Satellite Symposium

Access

Like

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

Event: Heart Failure 2025

Topic: Treatment

Session type: Satellite Symposium

Access

Like

Early pre-discharge phase and guidelines implementation

Event: Heart Failure 2024

Topic: Treatment

Session type: Case-Based Session

Access

Like

Interventional therapies in heart failure - from the left heart side to the right and back

Event: Heart Failure 2024

Topic: Device Therapy

Session type: Satellite Symposium

Access

Like

Going beyond foundational therapy in HFrEF: what is the role of sGC stimulators?

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Access

Like

Late breaking clinical trials

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Access

Like

Worsening heart failure: a critical event

Event: Heart Failure 2023

Topic: Acute Heart Failure

Session type: Symposium

Access

Like

undefined undefined undefined

Contributor content

A time of evolution in HFrEF: a new pillar blueprint

Fine-tuning patient care: a case-based exploration of finerenone in heart and kidney disease

Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Treatment of iron deficiency in heart failure: new evidence and practical guidance

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

Early pre-discharge phase and guidelines implementation

Interventional therapies in heart failure - from the left heart side to the right and back

Going beyond foundational therapy in HFrEF: what is the role of sGC stimulators?

Late breaking clinical trials

Worsening heart failure: a critical event

ESC 365 is supported by